These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1980606)

  • 1. No evidence for loss of alleles at 11p in HBV negative hepatocellular carcinomas.
    Kiechle-Schwarz M; Scherer G; Kovacs G
    Genes Chromosomes Cancer; 1990 Mar; 1(4):312-4. PubMed ID: 1980606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas.
    Wang HP; Rogler CE
    Cytogenet Cell Genet; 1988; 48(2):72-8. PubMed ID: 2904349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of somatic heterozygosity in hepatocellular carcinoma.
    Walker GJ; Hayward NK; Falvey S; Cooksley WG
    Cancer Res; 1991 Aug; 51(16):4367-70. PubMed ID: 1678314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
    Slagle BL; Zhou YZ; Butel JS
    Cancer Res; 1991 Jan; 51(1):49-54. PubMed ID: 1670994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelotype study of primary hepatocellular carcinoma.
    Fujimori M; Tokino T; Hino O; Kitagawa T; Imamura T; Okamoto E; Mitsunobu M; Ishikawa T; Nakagama H; Harada H
    Cancer Res; 1991 Jan; 51(1):89-93. PubMed ID: 1670995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma.
    Kahng YS; Lee YS; Kim BK; Park WS; Lee JY; Kang CS
    J Gastroenterol Hepatol; 2003 Apr; 18(4):430-6. PubMed ID: 12653892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma.
    Tokino T; Matsubara K
    J Virol; 1991 Dec; 65(12):6761-4. PubMed ID: 1682510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma.
    Rogler CE; Sherman M; Su CY; Shafritz DA; Summers J; Shows TB; Henderson A; Kew M
    Science; 1985 Oct; 230(4723):319-22. PubMed ID: 2996131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma.
    Tsuda H; Zhang WD; Shimosato Y; Yokota J; Terada M; Sugimura T; Miyamura T; Hirohashi S
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6791-4. PubMed ID: 2168560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China.
    Becker SA; Zhou YZ; Slagle BL
    Cancer Res; 1996 Nov; 56(21):5092-7. PubMed ID: 8895769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.
    Buetow KH; Murray JC; Israel JL; London WT; Smith M; Kew M; Blanquet V; Brechot C; Redeker A; Govindarajah S
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8852-6. PubMed ID: 2573067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.
    Emi M; Fujiwara Y; Nakajima T; Tsuchiya E; Tsuda H; Hirohashi S; Maeda Y; Tsuruta K; Miyaki M; Nakamura Y
    Cancer Res; 1992 Oct; 52(19):5368-72. PubMed ID: 1356616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion mapping of chromosome 11 in carcinoma of the bladder.
    Shaw ME; Knowles MA
    Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity on chromosome 16 in hepatocellular carcinoma.
    Sakai K; Nagahara H; Abe K; Obata H
    J Gastroenterol Hepatol; 1992; 7(3):288-92. PubMed ID: 1351753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma.
    Zhang WD; Hirohashi S; Tsuda H; Shimosato Y; Yokota J; Terada M; Sugimura T
    Jpn J Cancer Res; 1990 Feb; 81(2):108-11. PubMed ID: 1970554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas in Korea.
    Lee HS; Kim ST; Kim CY
    J Korean Med Sci; 1990 Sep; 5(3):145-8. PubMed ID: 1965776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequences which flank an 11p deletion observed in an hepatocellular carcinoma map to 11p13.
    Fisher JH; Scoggin CH; Rogler CE
    Hum Genet; 1987 Jan; 75(1):66-9. PubMed ID: 3026949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
    Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
    Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.